Wednesday, April 15, 2015
Dual Pricing for Medicines: Is the European Jurisprudence Accepted by National Courts? (Spain)
Cani Fernandez and Cristina Vila Gisbert, Cuatrecasas ask Dual Pricing for Medicines: Is the European Jurisprudence Accepted by National Courts? (Spain) ABSTRACT: In Glaxo, the Court of Justice decided that dual-pricing strategies by pharmaceutical companies restrict competition by their object...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment